|
DSpace at RU >
University Library >
Academic bibliography >
Files in This Item:
| File |
Description |
Size | Format |
| publisher's version | 132.33 kB | Adobe PDF | Under Embargo
|
|
| Title: | Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. |
| Author(s): | Virgolini, I. Ambrosini, V. Bomanji, J.B. Baum, R.P. Fanti, S. Gabriel, M. Papathanasiou, N.D. Pepe, G. Oyen, W.J.G. (09080497X) Cristoforo, C. De Chiti, A. |
| Publication year: | 2010 |
| Document type: | Article / Letter to editor |
| Journal: | European Journal of Nuclear Medicine and Molecular Imaging |
| ISSN: | 1619-7070 |
| Volume: | vol. 37 |
| Issue: | iss. 10 |
| Start page: | p. 2004 |
| End page: | p. 2010 |
| Abstract: | The aim of these guidelines is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging using 68Ga-DOTA-conjugated peptides, analogues of octreotide, that bind to SST receptors. This imaging modality should not be regarded as the only approach to visualizing tumours expressing SST receptors or as excluding other imaging modalities useful for obtaining comparable results. The corresponding guidelines of 111In-pentetreotide scintigraphy imaging have been considered and partially integrated with this text. The same has been done with the relevant and recent literature in this field and the final result has been discussed by distinguished experts. |
| Subject: | ONCOL 3: Translational research |
| Organization: | UMCN Extern Nuclear Medicine |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/89608
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|